Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v12-FR
Language French French
Date Updated 2023-08-12 2023-08-12
Drug Identification Number 02508087 02508087
Brand name TRI-CIRA 21 TRI-CIRA 21
Common or Proper name NORGESTIMATE / ETHINYL ESTRADIOL NORGESTIMATE / ETHINYL ESTRADIOL
Company Name APOTEX INC APOTEX INC
Ingredients ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE
Strength(s) 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 21 BLS 21 BLS
ATC code G03AB G03AB
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-04 2023-04-04
Estimated end date 2023-08-08 2023-08-08
Actual end date 2023-08-11 2023-08-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments